Cita APA

Harding, J. J., Piha-Paul, S., Shah, R., Murphy, J., Cleary, J. M., Shapiro, G. I., & Braña Garcia, I. (2023). Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.

Citación estilo Chicago

Harding, James J., Sarina Piha-Paul, Ronak Shah, Jessica Murphy, J. M. Cleary, G. I. Shapiro, y Irene Braña Garcia. Antitumour Activity of Neratinib in Patients With HER2-mutant Advanced Biliary Tract Cancers. 2023.

Cita MLA

Harding, James J., et al. Antitumour Activity of Neratinib in Patients With HER2-mutant Advanced Biliary Tract Cancers. 2023.